NCT02728492 Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy Status COMPLETED Phase PHASE1
NCT02726997 Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02722369 STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) Status TERMINATED Phase PHASE2
NCT02718417 Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) Status TERMINATED Phase PHASE3
NCT02716038 Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC Status COMPLETED Phase PHASE2
NCT02713386 Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02703623 Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02703272 A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE3
NCT02684227 Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02684058 Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors Status COMPLETED Phase PHASE2
NCT02672098 Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer Status COMPLETED Phase PHASE1
NCT02670109 Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients Status UNKNOWN Phase PHASE2
NCT02665039 A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function Status COMPLETED Phase PHASE2
NCT02662634 A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT02657434 A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) Status COMPLETED Phase PHASE3
NCT02639650 Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Status RECRUITING Phase PHASE3
NCT02638428 Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy Status UNKNOWN Phase PHASE2
NCT02633800 Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN ) Status TERMINATED Phase PHASE2